CEO SUMMARY: It’s a cryptic situation as of press time. Quest Diagnostics issued a public statement on July 1 stating that its acquisition of SmithKline Beecham Clinical Laboratories would not close on July 2, as expected. Since that date, there’s been no further comment on the situation. Wall Street analysts and Quest competitors are watching …
Quest Holds Off on SBCL, Leaves the Door Open Read More »
